NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 9, 2017
Insider Transaction Report
Form 4
Regan William J.
SVP of lobal Regulatory Strate
Transactions
- Award
NAVB Common Stock, $.001 par value
2017-02-06$0.52/sh+79,155$41,161→ 116,962 total
Footnotes (1)
- [F1]Granted in lieu of cash bonus under 2015 and 2016 bonus plans.